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Abstract –The key precursor, N2-(N,N-dimethylaminomethylene)-1’-O-(4- 
methoxybenzyl)-3-[2-(4-nitrophenyl)ethyl]ciliapterin (15) was efficiently 
prepared from D-xylose via an improved route.  The first synthesis of 
2’-O-(α-D-mannopyranosyl)ciliapterin (2c) was achieved by treatment of 15 with 
2,3,4,6-tetra-O-benzoyl-α-D-mannnopyranosyl bromide in the presence of silver 
triflate and tetramethylurea, followed by removal of the protecting groups.  
INTRODUCTION 
Some pterins having a hydroxyalkyl side-chain at C-6, such as biopterin (1a) and ciliapterin 
(L-threo-biopterin) (2a), have been found as glycosidic forms in certain prokaryotes.  As examples of 
pterin glycosides from green sulfur photosynthetic bacteria, limipterin (1b) and tepidopterin (2b) were 
isolated from Chlorobium limicola f. thiosulfatophilum1 and Chlorobium tepidum,2 respectively.  
Meanwhile, from cyanobacteria have been found 2’-O-(α-D-glucopyranosyl)biopterin (1c) (from 
Anacystis nidulans,3 Synechococcus sp.,4 and Spirulina platensis)5 and 2’-O-(α-D- 
mannopyranosyl)ciliapterin (2c) (from Aphanizomenon flos-aquae).6,7  Various other glycosides 
consisting of different pterins and sugar moieties have also been found in nature, although some of them 
have remained unclear concerning the position and the anomeric structure of the glycosidic linkage.8 
 
 
 
 The physiolosical functions of these pterin glycosides appear to have been little investigated9 in contrast 
to the well-documented parent pterin: e.g., 1a exhibits enzyme cofactor activity in hydroxylation of 
aromatic amino acid10 and synthesis of nitric oxide11 as the form of its tetrahydro derivative.  Attempts 
at preparing natural pterin glycosides have also scarcely been made so far, except for our synthetic studies 
on limipterin (1b) from 1a12 and tepidopterin (2b) from D-glucitol via an appropriately protected 
ciliapterin derivative (15)13 (Scheme 1).  In this scheme, the L-threo configuration of the side chain of 
15 was derived from those of C-3 and C-4 of L-xylose prepared from D-glucitol in three steps.14 
In the present study, we have attempted to improve preparation of the key intermediate (15) via an 
alternative route involving inversions of C-3 and C-4 configurations of D-xylose.  We also describe the 
first synthesis of a natural pterin glycoside, 2’-O-(α-D-mannopyranosyl)ciliapterin (2c). 
 
 
Scheme 1 
RESULTS AND DISCUSSION 
D-Xylose was converted into 5-deoxy-1,2-O-isopropylidene-α-D-xylofuranose (4) via the 5-O-tosyl 
derivative (3) according to the reported procedures15 with a slightly modification (Scheme 2).  The 
transformation of D-xylo configuration of 4 into L-lyxo form was achieved by way of the 3-enofuranose 
intermediate.16  Namely, compound 4 was oxidized with oxalyl chloride-DMSO to give the 
α-D-erythro-pentofuranos-3-ulose derivative (5)17 (in 98% yield), which was treated with acetic 
anhydride in pyridine at 80 °C to afford the enol acetate (6) in 74%.  Hydrogenation of 6 in the presence 
of Pd-C exclusively proceeded from less hindered upper side of the furanose ring, providing the 
3-O-acetyl-L-lyxofuranose derivative (7). 
The 3-O-acetyl group of 7 was then cleaved with sodium methoxide in methanol to yield 
5-deoxy-1,2-O-isopropylidene-β-L-lyxofuranose (8).  Treatment of 8 with p-methoxybenzyl chloride 
and sodium hydride in DMF gave the 3-O-PMB derivative (9), which afforded 
5-deoxy-3-O-PMB-L-lyxose (10) by hydrolysis in 70% acetic acid.  The selective oxidation of 
2-hydroxy group of 10 with cupric acetate18 provided the L-erythro-pentos-2-ulose derivative (11). 
 
  
 
Scheme 2 
 
The pteridine ring formation of 11 with 2,5,6-triamino-4-hydroxypyrimidine (12) and the subsequent 
introduction of protecting groups were carried out by employing the reported procedures13 (Scheme 3).  
Namely, condensation of 11 and 12 in an aqueous sodium bicarbonate solution afforded an inseparable 
mixture of the ciliapterin derivative (13a) and its C-7 substituted isomer (13b) in a ratio of 75:25.  These 
products were separated after the three-step-procedures for introduction of N,N-dimethylaminomethylene, 
acetyl, and 2-(4-nitrophenyl)ethyl (NPE) groups, providing 2’-O-acetyl-N2-(N,N-dimethylamino- 
methylene)-1’-O-PMB-3-NPE-ciliapterin (14a) (52% overall yield from 11) and its C-7 substituted 
congener (14b) (17%).  Methanolysis of the isolated 14a in the presence of sodium methoxide yielded 
the 1’-O-PMB derivative (15), a key precursor for the 2’-O-glycosylation. 
As an appropriate glycosyl donor for preparation of 2c, 2,3,4,6-tetra-O-benzoyl-α-D-mannopyranosyl 
bromide (16),19 available from D-mannose in two steps, was utilized.  Thus, glycosylation of 15 was 
attained by the condensation with 16 in the presence of silver triflate and tetramethylurea (TMU) in 
dichloromethane at room temperature for 3 h, affording the 2’-O-(α-D-mannopyranosyl)ciliapterin 
derivative (17) in 77% yield.  The α-anomeric structure of 17 was derived from the results of NOE 
experiments of the 1H-NMR spectrum in addition to the characteristic tendency of the predominant 
α-glycoside formation of D-mannose.  In an NOESY spectrum of 17, no cross peaks with respect to 
H-1/H-3 and H-1/H-5 of the D-mannopyranosyl moiety were detected, whereas a strong NOE was 
observed between the 1,3-syn-diaxial H-3 and H-5 protons, indicating an equatorial orientation of H-1, 
namely an α-anomeric form, of 17. 
Removal of the protecting groups of 17 was carried out as follows: oxidation of 17 with 
2,3-dichloro-5,6-dicyano-1,4-benzoquinone (DDQ) afforded 1’-O-free 18 (in 83% yield), which was 
treated with sodium methoxide in methanol to cleave benzoyl groups, and then with aqueous ammonia to 
cleave the N,N-dimethylaminomethylene group.  The NPE group was finally removed by treatment with 
DBU,20 thus providing 2’-O-(α-D-mannopyranosyl)ciliapterin (2c) in 85% (overall yield from 18).  The 
precise structure of 2c was established by 1H-NMR spectrum with the aid of decoupling techniques and 
 2D COSY measurement (Table 1).  It is noteworthy that an extraordinary upfield shift was observed for 
the H-5 signal (δ 2.51) of the mannopyranosyl moiety compared with that of α-D-mannopyranose (δ 
3.49).21  This suggests that 2c in a DMSO solution exists in such a conformation as H-5 of the sugar 
moiety locating above the pterin ring where an appreciable shielding effect is exerted. 
Thus the first synthesis of ciliapterin D-mannnoside (2c) was achieved utilizing an improved synthesis of 
the key precursor (15) by way of an alternative route from D-xylose in a 1.5 time better overall yield.  
Extension of this work including applications of these findings in synthesizing other natural pterin 
glycosides and their analogs is in progress. 
 
 
Scheme 3 
EXPERIMENTAL 
All reactions were monitored by TLC (Merck Silica gel 60 F254) with an appropriate solvent system [(A) 
1:2, (B) 1:1 AcOEt-hexane, (C) AcOEt, and (D) 5:3:1 2-PrOH-AcOEt-H2O]. Column chromatography 
was performed with Daiso Silica Gel IR-60/210w.  Components were detected by exposing the plates to 
UV light and/or 20% H2SO4-EtOH, with subsequent heating.  Optical rotations were measured with a 
JASCO P-1020 polarimeter in CHCl3.  The NMR spectra were measured in CDCl3 with Varian Unity  
 Table 1.  600 MHz 1H-NMR Spectral Parameters for ciliapterin derivatives (15, 17, 18, 2c).a 
—————————————————————————————————————————————— 
Chemical shifts / δ (coupling constants / Hz) 
 Pterin moiety Me2NCH=N-2 NPE-N(3)  
Com-   ——————————  ———————  —————————————— 
pound H-7 H-1’ H-2’ H3-3’ Me2N CH=N H(o) H(m) CH2CH2N CH2N Other signals 
  (J1’,2’) (J2’,3’)     (Jo,m) (2JH,H) (3JH,H) (2JH,H)  
—————————————————————————————————————————————— 
15 8.92 4.57 4.04 1.17 3.24, 3.19 8.88 7.40 8.13 3.16 4.61, 4.59 3.78 (MeO of PMBb) 
  (5.6) (6.4)    (8.7)   (7.8) (12.5) 2.78 (HO-2’) 
17 9.03 4.91 4.35 1.16 3.25, 3.19 8.90 7.34 8.09 3.13 4.56 3.67 (MeO of PMBc) 
  (6.6) (6.4)    (8.5)   (7.8)  
18 9.12 5.10 4.53 1.31 3.24, 3.17 8.86 7.35 8.11 3.10, 3.08 4.51 4.08 (HO-1’)   
  (4.4) (6.4)    (8.5) (13.1) (7.8)  
2c 8.69 4.66 4.07 1.12 7.15 (H2N-2)d 11.30 [H-N(3)]d  5.62 (HO-1’)d 
  (3.7) (6.3)     
—————————————————————————————————————————————— 
Gycosyl moiety 
 H-1 H-2 H-3 H-4 H-5 Ha-6 Hb-6 Other signals 
 (J1,2) (J2,3) (J3,4) (J4,5) (J5,6a) (J6a,6b) (J5,6b) 
—————————————————————————————————————————————— 
17 5.19 5.63 5.86 6.09 4.53 4.48 4.20 8.09, 8.02, 7.99, 7.80 [Bz(o)] 
 (1.9) (3.3) (10.1) (10.2) (2.4) (12.5) (3.7) 7.41, 7.34, 7.34, 7.23 [Bz(m)] 
        7.56, 7.56, 7.47, 7.40 [Bz(p)] 
18 5.27 5.65 5.75 6.08 4.23 4.55 4.23 8.06, 8.01, 7.92, 7.80 [Bz(o)] 
 (1.9) (3.2) (10.2) (10.2) (2.7) (12.4) (3.5) 7.37, 7.37, 7.33, 7.24 [Bz(m)] 
        7.57, 7.54, 7.45, 7.40 [Bz(p)] 
2c 4.65 3.48 3.18 3.30 2.51 3.22 3.18 4.62, 4.44, 4.18, 3.37 (HO-2,3,4,6)d 
 (1.2) (2.9) (9.5) (9.5) (1.6) (11.7) (3.4)  
—————————————————————————————————————————————— 
a 15, 17, 18 in CDCl3, 2c in DMSO-d6.  b δ 7.21 [H(o), Jo,m = 8.7 Hz], 6.84 [H(m)], 4.47, 4.41 (CH2, 2J = 11.2 Hz). 
c δ 7.28 [H(o), Jo,m = 8.8 Hz], 6.78 [H(m)], 4.54, 4.50 (CH2, 2J = 11.2 Hz).  d Confirmed by D2O exchange.  
 
 
Inova AS600 (600 MHz for 1H, 151 MHz for 13C) at 23 °C, unless otherwise stated.  The solvent peak 
was used as an internal standard for chemical shifts: in CDCl3, δ 7.26 for 1H, 77.00 for 13C; in DMSO-d6, 
δ 2.50 for 1H, 39.70 for 13C.  The assignments of 13C signals were made with the aid of 2D C-H COSY 
measurements. 
 
5-Deoxy-1,2-O-isopropylidene-α-D-xylofuranose (4).15 
The following modification of the literature procedures15 was made.  To a solution of 3 (7.82 g, 22.7 
mmol) in dry Et2O (80 mL) was added lithium aluminum hydride (1.72 g, 45.5 mmol) at 0 °C under 
argon.  The mixture was stirred at rt for 6 h, and then water was added.  The precipitates were filtered 
 off and washed with CHCl3.  The filtrate was washed with aqueous NaCl, dried (Na2SO4), and 
evaporated in vacuo.  The residue was purified by column chromatography with 1:2 AcOEt-hexane to 
give 4 (3.72 g, 94%) as colorless needles: mp 67–68 °C (from 1:1 AcOEt-hexane) (lit.,15a mp 66–67 °C, 
84% yield); Rf = 0.42 (B). 
 
5-Deoxy-1,2-O-isopropylidene-α-D-erythro-pentofuranose-3-ulose (5).17 
To a solution of oxalyl chloride (5.00 mL, 57.3 mmol) in dry CH2Cl2 (30 mL) was added a solution of 
DMSO (6.50 mL, 91.6 mmol) in dry CH2Cl2 (10 mL) at –60 °C.  After having been stirred for 20 min, a 
solution of 4 (4.03 g, 23.1 mmol) in dry CH2Cl2 (5.0 mL) was slowly added at –60 °C.  Stirring was 
continued at the same temperature for 8 h and then TEA (18.0 mL, 129 mmol) was added.  The mixture 
was stirred at rt for 30 min, diluted with CHCl3, washed with water, dried (Na2SO4), and evaporated in 
vacuo.  The residue was purified by column chromatography with 1:2 AcOEt-hexane to give 8 (3.91 g, 
98%) [lit., 81%17a (by use of RuO4), 83%17b (by use of PCC)] as a colorless syrup: Rf = 0.33 (B). 
 
3-O-Acetyl-5-deoxy-1,2-O-isopropylidene-α-D-glycero-pent-3-enofuranose (6). 
To a solution of 5 (2.00 g, 11.6 mmol) in dry pyridine (15.0 mL) was added acetic anhydride (6.0 mL, 63 
mmol).  The mixture was stirred at 80 °C for 24 h and then concentrated in vacuo.  The residue was 
diluted with AcOEt and the precipitate was filtered off.  The filtrate was evaporated in vacuo and the 
residue was purified by column chromatography with 1:4 AcOEt-hexane to give 6 (1.84 g, 74%) as a pale 
yellow syrup: Rf = 0.68 (A); 1H-NMR δ 1.46, 1.50 (3H each, 2s, CMe2), 1.77 (3H, d, 5J2,5 = 1.3 Hz, H-5), 
2.21 (3H, s, AcO-3), 5.38 (1H, dq, J1,2 = 5.4 Hz, H-2), 5.98 (1H, d, H-1).  Anal. Calcd for C10H14O5: C, 
56.07; H, 6.59.  Found: C, 55.88; H, 6.80. 
 
3-O-Acetyl-5-deoxy-1,2-O-isopropylidene-β-L-lyxofuranose (7). 
To a solution of 6 (1.80 g, 8.41 mmol) in AcOEt (25 mL) was added 10% Pd-C (1.50 g, 1.41 mmol).  
The mixture was stirred at rt for 4 h under atmospheric pressure of hydrogen.  The catalyst was filtered 
off and the filtrate was evaporated in vacuo.  The residue was purified by short-path column 
chromatography with 1:2 AcOEt-hexane to give 7 (1.71 g, 94%) as a colorless syrup: Rf = 0.46 (A); [α]D24 
+65.4˚ (c 3.33); 1H-NMR δ 1.35 (3H, d, J4,5 = 6.6 Hz, H-5), 1.36, 1.57 (3H each, 2s, CMe2), 2.15 (3H, s, 
AcO-3), 4.27 (1H, quint, J3,4 = 6.1 Hz, H-4), 4.78 (1H, dt, J2,3 = 5.6, J1,2 = 4.4 Hz, H-2), 4.96 (1H, dd, 
H-3), 5.72 (1H, d, H-1); 13C-NMR δ 15.71 (COCH3), 20.69 (C-5), 26.70, 26.83 (Me2C), 72.53 (C-4), 
75.71 (C-3), 79.57 (C-2), 104.50 (C-1), 114.37 (Me2C), 170.38 (COCH3).  Anal. Calcd for C10H16O5: C, 
55.55; H, 7.46.  Found: C, 55.41; H, 7.62. 
 
5-Deoxy-1,2-O-isopropylidene-β-L-lyxofuranose (8). 
Compound 7 (975 mg, 4.51 mmol) was dissolved in dry MeOH (10 mL) and then NaOMe (28% in 
MeOH, 0.30 mL, 1.5 mmol) was added at 0 °C.  The mixture was stirred at rt for 2 h and neutralized 
with Amberlite IR-120(H+).  The resin was filtered off and the filtrate was evaporated in vacuo.  The 
residue was purified by column chromatography with 1:2 AcOEt-hexane to give 8 (715 mg, 91%) as 
 colorless needles: mp 86–88 °C (from AcOEt-hexane); Rf = 0.25 (A); [α]D24 +9.16° (c 2.21); 1H-NMR δ 
1.35 (3H, d, J4,5 = 6.4 Hz, H-5), 1.38, 1.60 (3H each, 2s, CMe2), 2.60 (1H, d, J3,OH = 8.1 Hz, HO-3), 4.11 
(1H, quint, J3,4 = 6.1 Hz, H-4), 4.13 (1H, dt, J2,3 = 5.9 Hz, H-3), 4.63 (1H, dd, J1,2 = 4.4 Hz, H-2), 5.71 
(1H, d, H-1); 13C-NMR δ 15.18 (C-5), 26.69, 26.83 (Me2C), 70.59 (C-4), 78.36 (C-3), 80.09 (C-2), 
104.58 (C-1), 114.09 (Me2C).  Anal. Calcd for C8H14O4: C, 55.16; H, 8.10.  Found: C, 54.99; H, 8.21. 
 
5-Deoxy-1,2-O-isopropylidene-3-O-(4-methoxybenzyl)-β-L-lyxofuranose (9). 
Compound 8 (292 mg, 1.68 mmol), p-methoxybenzyl chloride (0.450 mL, 3.30 mmol), and 
tetrabutylammonium iodide (180 mg, 0.49 mmol) were dissolved in DMF (10 mL) and, with stirring, 
sodium hydride (60% in mineral oil, 130 mg, 3.25 mmol) was added at 0 °C under argon.  The mixture 
was stirred at rt for 12 h, diluted with saturated NH4Cl (5 mL), and evaporated in vacuo.  The residue 
was dissolved in CHCl3, washed with water, dried (Na2SO4), and evaporated in vacuo.  The residue was 
purified by column chromatography with 1:3 AcOEt-hexane to give 15 (465 mg, 94%) as a colorless 
syrup: [α]D24 +36.2° (c 2.91); Rf = 0.50 (A); 1H-NMR δ 1.33, 1.61 (3H each, 2s, CMe2), 1.41 (3H, d, J4,5 = 
6.8 Hz, H-5), 3.81 (3H, s, MeO), 3.92 (1H, dd, J3,4 = 7.1, J2,3 = 5.1 Hz, H-3), 4.11 (1H, quint, H-4), 4.55, 
4.64 (1H each, 2d, 2J = 11.8 Hz, CH2O-3), 4.58 (1H, dd, J1,2 = 4.2 Hz, H-2), 5.68 (1H, d, H-1), 6.88, 7.29 
(2H each, 2d, Jo,m = 8.8 Hz, C6H4); 13C-NMR δ 16.91 (C-5), 26.01, 26.64 (Me2C), 55.24 (MeO), 72.04 
(CH2O), 76.97 (C-4), 77.04 (C-3), 78.97 (C-2), 104.42 (C-1), 113.41 (Me2C), 113.79 [C(m) of PMB], 
129.51 [C(o) of PMB], 129.69 [C(ipso) of PMB], 159.38 [C(p) of PMB].  Anal. Calcd for C16H22O5: C, 
65.29; H, 7.53.  Found: C, 65.18; H, 7.64. 
 
5-Deoxy-3-O-(4-methoxybenzyl)-α ,β-L-lyxofuranoses (10). 
A solution of 9 (200 mg, 0.679 mmol) in 70% AcOH (10 mL) was heated at 40 °C for 4 h.  After 
addition of pyridine (0.20 mL), the mixture was evaporated in vacuo.  The residue was purified by 
column chromatography to give an inseparable anomeric mixture (α:β = 33:67) of 10 (154 mg, 89%) as a 
colorless syrup: Rf = 0.08 (A), 0.15 (B); 1H-NMR for α-anomer δ 1.27 (3H, d, J4,5 = 6.6 Hz, H3-5), 2.87 
(1H, d, J2,OH = 5.6 Hz, HO-2), 3.07 (1H, d, J1,OH = 2.9 Hz, HO-1), 3.81 (3H, s, MeO), 4.09 (1H, td, J2,3 = 
5.4, J1,2 = 1.5 Hz, H-2), 4.11 (1H, d, J3,4 = 4.9 Hz, H-3), 4.38 (1H, qd, H-4), 4.54, 4.56 (1H each, 2d, 2J = 
11.2 Hz, CH2O-3), 5.28 (1H, dd, H-1), 6.89, 7.27 (2H each, 2d, Jo,m = 8.8 Hz, C6H4); 1H-NMR for 
β-anomer δ 1.33 (3H, d, J4,5 = 6.6 Hz, H3-5), 2.89 (1H, d, J2,OH = 9.5 Hz, HO-2), 3.46 (1H, d, J1,OH = 11.2 
Hz, HO-1), 3.81 (3H, s, MeO), 3.86 (1H, d, J2,3 = 4.6, J3,4 = 3.9 Hz, H-3), 4.06 (1H, qd, H-4), 4.10 (1H, dt, 
J1,2 = 4.4 Hz, H-2), 4.62, 4.64 (1H each, 2d, 2J = 11.2 Hz, CH2O-3), 5.05 (1H, dd, H-1), 6.89, 7.27 (2H 
each, 2d, Jo,m = 8.8 Hz, C6H4).  Anal. Calcd for C13H18O5: C, 61.41; H, 7.13.  Found: C, 61.20; H, 7.29. 
 
5-Deoxy-3-O-(4-methoxybenzyl)-α ,β -L-threro-pentos-2-uloses (11).13 
Compound 10 (250 mg, 0.983 mmol) was dissolved in MeOH (6 mL) and water (3 mL).  The solution 
was refluxed and then cupric acetate hydrate (1.00 g, 5.01 mmol) was added.  The mixture was refluxed 
for 1 h and then precipitates were filtered off and washed with AcOEt.  The filtrate was concentrated in 
vacuo and the residue was separated by column chromatography with 1:2 AcOEt-hexane to give 17 (126 
 mg, 51% yield) as a colorless syrup; Rf = 0.33–0.24 (B).  From the slower-eluting fraction, compound 10 
(51.0 mg, 20%) was recovered. 
 
N2-(N,N-Dimethylaminomethylene)-1’-O-(4-methoxybenzyl)-3-[2-(4-nitrophenyl)ethyl]ciliapterin 
(15).13 
By use of the same procedures described in the literature,13 compound 11 was converted into 15 in five 
steps: Rf = 0.06 (C); 1H-NMR, see Table 1. 
 
N2-(N,N-Dimethylaminomethylene)-1’-O-(4-methoxybenzyl)-3-[2-(4-nitrophenyl)ethyl]-2’-O- 
(2,3,4,6-tetra-O-benzoyl-α-D-mannopyranosyl)ciliapterin (17). 
To a solution of 15 (35.0 mg, 0.0623 mmol), 2,3,4,6-tetra-O-benzoyl-α-D-mannopyranosyl bromide (16)  
(123 mg, 0.187 mmol) and TMU (0.008 mL, 0.066 mmol) in dry CH2Cl2 (1.0 mL) was added silver 
triflate (32.0 mg, 0.125 mmol).  The mixture was stirred at rt for 3 h in the dark, diluted with CHCl3, and 
filtered through Celite.  The filtrate was washed with aqueous NaHCO3, dried (Na2SO4), and evaporated 
in vacuo.  The residue was purified by column chromatography with 2:1 AcOEt-hexane to give 17 (54.7 
mg, 77%) as a pale yellow foam: Rf = 0.48 (C); 1H-NMR, see Table 1.  Anal. Calcd for C62H57N7O15: C, 
65.31; H, 5.04.  Found: C, 65.09; H, 5.19. 
 
N2-(N,N-Dimethylaminomethylene)-3-[2-(4-nitrophenyl)ethyl]-2’-O-(2,3,4,6-tetra-O-benzoyl-α-D- 
mannopyranosyl)ciliapterin (18). 
To a solution of 17 (74.9 mg, 0.0657 mmol) in CH2Cl2 (2.0 mL) containing water (0.10 mL) was added 
DDQ (89.5 mg, 0.394 mmol).  The mixture was stirred at rt for 2 h and then diluted with CHCl3.  The 
mixture was washe with aqueous NaHCO3, dried (MgSO4), and evaporated in vacuo.  The residue was 
purified by column chromatography with 1:99 MeOH-CHCl3 to give 18 (55.9 mg, 83%) as pale yellow 
syrup: Rf = 0.12 (C); 1H-NMR, see Table 1.  Anal. Calcd for C54H49N7O14: C, 63.59; H, 4.84.  Found: 
C, 63.70; H, 5.01. 
 
2’-O-(α-D-Mannnopyranosyl)ciliapterin (2c). 
Compound 18 (55.9 mg, 0.0548 mmol) was dissolved in dry MeOH (2.0 mL) and then NaOMe (28% in 
MeOH, 0.030 mL, 0.15 mmol) was added at 0 °C.  The mixture was stirred at rt for 1 h and neutralized 
with Amberlite IR-120(H+).  The resin was filtered off and the filtrate was evaporated in vacuo.  The 
residue was dissolved in MeOH (4.0 mL) and 28% aqueous ammonia solution (4.0 mL) was added.  The 
mixture was stirred at rt for 12 h and evaporated in vacuo.  The residue was dissolved in DMF (1.0 mL) 
and DBU (0.050 mL, 0.33 mmol) was added.  The mixture was stirred at rt for 20 h, diluted with water 
(4.0 mL), and neutralized with Amberlite FPC3500(H+).  The resin was filtered off and the filtrate was 
evaporated in vacuo.  The residue was washed with CHCl3 and dried under reduced pressure to give 2c 
(18.6 mg, 85%) as pale yellow solid: Rf = 0.25 (D); 1H-NMR, see Table 1; 13C-NMR (DMSO-d6) δ 14.90 
(C-3’), 60.66 (C-6*), 66.34 (C-4*), 70.93 (C-2*), 70.98 (C-3*), 72.82 (C-2’), 73.73 (C-5*), 75.09 (C-1’), 
96.98 (C-1*), 127.45 (C-4a), 148.35 (C-7), 151.40 (C-6), 155.20 (C-8a), 156.51 (C-2), 163.15 (C-4), *for 
 glycosyl moiety.  Anal. Calcd for C15H21N5O8: C, 45.11; H, 5.30.  Found: C, 44.85; H, 5.51. 
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